PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

40,350 stories, page 376 of 673

Advanced search
🌍Researchdoi.orgTier 1 · Research record

Differences in reactive metabolite formation and cytochrome P450 binding between acetaminophen and its bicyclo[1.1.1]pentane bioisostere

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Effects of different exercise modalities and doses on glycated hemoglobin in patients with type 2 diabetes mellitus and overweight or obesity: a systematic review and Bayesian multilevel network meta-analysis

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Prediabetes in Ontario: improving surveillance for better disease prevention

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

The first epidemiological study of presymptomatic type 1 diabetes among first-degree relatives in Japan: PREP-T1D study

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Deep learning reconstruction dual-energy computed tomography for gastrointestinal system tumors: low-kiloelectron volt imaging vs routine imaging

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Prejudice against jagged personality profiles: Rethinking bias in psychological research and clinical practice

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Pharmaceutical residues as emerging contaminants: Health impacts and the financial burden of exposure

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Risk of major structural birth defects following repeat mRNA COVID-19 vaccination in the first trimester: a population-based cohort study

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Prognostic Value of the Geriatric Nutritional Risk Index for Long-Term All-Cause Mortality in Older Patients with Non-ST-Segment Elevation Myocardial Infarction

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Nutritional prehabilitation for robot-assisted radical prostatectomy: A proposed clinical framework integrating body composition analysis

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Medium-chain triglyceride supplementation in preterm infants: A prospective cohort study

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Resting-state EEG for continuous prognostic monitoring and prediction of coma recovery after acute brain injury

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Video-oculography-derived oculomotor indices in Parkinson’s disease: Methodological limitations restrict clinical translation

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Natural history and radiological features of Rathke’s cleft cysts diagnosed on MRI: Analysis of 410 patients including 279 managed conservatively

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Safety of continuing antithrombotic therapy during lumboperitoneal shunting for idiopathic normal pressure hydrocephalus: A single-center retrospective analysis

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

MRI-assessed small vessel disease burden and gait performance in post-ischemic stroke hemiparesis

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

When findings hurt: Mental health effects of cerebral MRI screening in patients with Hereditary Hemorrhagic Telangiectasia

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Chronic Kidney Disease Does Not Influence Response to Terlipressin in Hepatorenal Syndrome–Acute Kidney Injury

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

AI-Assisted Capsule Endoscopy for Detection of Ulcers and Erosions in Crohn’s Disease: A Multicenter Validation Study

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Fecal Microbiota-Based Therapies Compared to Fecal Microbiota Transplantation for Preventing Recurrent C difficile Infection

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Multi-omics biomarker in adrenocortical carcinoma: a clinical-chemistry perspective

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Deep learning framework integrating 18F-FDG PET/CT and clinical data for early prediction of chemotherapy response in advanced breast cancer

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

The impact of food advertising on children's daily energy intake: does it differ by advertising content, format, or participant characteristics? A cross-over randomised controlled trial

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Emotions documented in clinical notes: An interpretative descriptive study

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Magnesium sulfate for neuroprotection: Approach to addressing clinical questions

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Rethinking the impact of dietary sodium and potassium on blood pressure to advance public health

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Development and Clinical Validation of a Protocol-Agnostic Machine Learning Platform for Automated Treatment Planning in External Beam Radiation Therapy

CrossrefOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Teva Pharmaceutical Industries Limited 2026 Q2 - Results - Earnings Call Presentation (NYSE:TEVA) 2026-07-31

Seeking AlphaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Zhejiang Tianyu Pharmaceutical Co. Ltd. Class A Revenue Breakdown – SZSE:300702

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Epi Biotech Co., Ltd. Revenue Breakdown – KRX:446440

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

J&J’s biotech progress could punish its 2027 profit

thestreet.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

IPO News | He Mei Pharmaceutical's Hong Kong IPO and full convertibility of its domestically held unlisted shares have received filing confirmation from the China Securities Regulatory Commission (CSRC).

moomoo.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech slides as investors appear to reset ahead of earnings

Quiver QuantitativeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Medipharco Pharmaceutical Joint Stock Co Revenue Breakdown – UPCOM:MTP

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why Breakthrough Therapies in Biotech Are Losing the Commercial Battle

NewsweekOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Northeast Pharmaceutical Group Co., Ltd. Class A Revenue Breakdown – SZSE:000597

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Novo drug trial fail deals setback to bid to expand beyond obesity

ReutersOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Veraxa Biotech Holding AG - Files To Register Resale Of Up To 25 Million Ordinary Shares - SEC Filing

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Novo Nordisk Shares Plunge After a Key Trial Fails. Should Investors Buy the Dip?

The Globe and MailOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Novo Nordisk Shares Plunge After a Key Trial Fails. Should Investors Buy the Dip?

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Rock Hill inks $1.5B investment deal with pharmaceutical company for former Panthers site

SC Daily GazetteOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Spartanburg pharmaceutical facility to close, layoff nearly 200 employees

FOX Carolina NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Novo Nordisk (CPSE:NOVO B) Misses The Mark In Phase 3 Heart Drug Trial

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The HIV shot that could change medicine is facing its biggest test: Getting to patients

businessinsider.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Guangzhou Wondfo Biotech Co., Ltd. Class A – SZSE:300482

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to sales forward of Guangzhou Wondfo Biotech Co., Ltd. Class A – SZSE:300482

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Guangzhou Wondfo Biotech Co., Ltd. Class A – SZSE:300482

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Sichuan Biokin Pharmaceutical Co., Ltd. Class A – SSE:688506

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech CEO explains how his company is using AI to detect cancer

Fox BusinessOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

This Biotech Stock Soars 107% After Key FDA Panel Vote on Skin Cancer Treatment

barrons.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

New Non-Opioid Analgesic Works Better Than Vicodin

Pain News NetworkOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Veraxa Biotech (VRXA) grows patent estate for BiTAC cancer platforms

stocktitan.netOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Regulatory Roundup—July 2026

PharmTech.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA weighs in on peptides, VA tests new use for popular drug and wildfire smoke returns

kgw.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Regeneron Pharmaceuticals, Inc. (REGN) Faces Securities Class Action Amid Disclosures About Key Trial's Protocol and Ultimate Failure - HBSS

MorningstarOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Best Toenail Fungus Laser Treatment for Safe, Drug-Free Results - View rFLgX2xij

Diario ASOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Menin Inhibitor Enzomenib Gains FDA Orphan Drug Designation in ALL

Targeted OncologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

NVO Stock Plummets as Novo Nordisk Heart Drug Fails Late-Stage Trial

inklOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech Stocks Facing FDA Decision In August 2026

RTTNewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Premature menopause increases risk of high blood pressure, study finds

The Pharmaceutical JournalOriginal source